Literature DB >> 24684962

Asthma medication use among U.S. adults 18 and older.

Maithili Deshpande1, Betty Chewning2, David Mott2, Joshua M Thorpe3, Henry N Young4.   

Abstract

BACKGROUND: Asthma is a chronic lung disease that currently affects an estimated 25 million Americans. One way to control the disease is by regular use of preventive asthma medications and controlled use of acute medications. However, little is known about adults with asthma and factors associated with their medication use.
OBJECTIVE: To identify factors associated with asthma medication use among U.S. adults aged 18 and older.
METHODS: Data were obtained from the 2006 to 2010 Medical Expenditure Panel Survey (MEPS). Medication use outcome variables include: a) daily use of a preventive asthma medication (yes/no) and b) overuse (3+) of acute inhalers in last 3 months (yes/no). The Andersen Behavioral Model of Health Care was used to guide the selection of independent variables. The independent variables were categorized as predisposing, enabling and medical need factors. Logistic regression models were used to examine the relationship between asthma medication use in adults with asthma. Point estimates were weighted to the U.S. non-institutionalized population, and standard errors were adjusted to account for the complex survey design.
RESULTS: Compared to Whites, minority adults 18 and older were less likely to use preventive asthma medication daily (Hispanic-OR: 0.72, CI: 0.54-0.96; African American-OR: 0.62, CI: 0.51-0.75 respectively). Similarly, Hispanic adults age 18 and older were at a significantly higher likelihood of overusing rescue medications compared to Whites (OR: 1.47, CI: 1.03-2.11). Non-metropolitan adults age 18 and older were more likely to overuse acute asthma medications than those from Metropolitan Statistical Area (OR: 1.57, CI: 1.15-2.16). Compared to older adults age 65 and over, late mid-life 50-64 year old adults were less likely to use a daily preventive asthma medication (OR: 0.67, CI: 0.54-0.83).
CONCLUSIONS: Race, rurality and age were important factors associated with poor asthma medication use in U.S. adults. Although this is a first step toward identifying factors that may influence the use of asthma medications, future studies are needed to develop and implement interventions to overcome issues to improve asthma care.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adults; Asthma; Disparities

Mesh:

Substances:

Year:  2014        PMID: 24684962     DOI: 10.1016/j.sapharm.2014.02.006

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  5 in total

1.  Optimal cut-off value and clinical usefulness of the Adherence Starts with Knowledge-12 in patients with asthma taking inhaled corticosteroids.

Authors:  Masaya Takemura; Masayuki Nishio; Kensuke Fukumitsu; Norihisa Takeda; Hiroya Ichikawa; Takamitsu Asano; Hiroki Tomita; Yoshihiro Kanemitsu; Kosho Yoshikawa; Akio Niimi
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

2.  Group-randomized trial of tailored brief shared decision-making to improve asthma control in urban black adults.

Authors:  Maureen George; Jean-Marie Bruzzese; Marilyn Lynn S Sommers; Michael V Pantalon; Haomiao Jia; Joseph Rhodes; Allison A Norful; Annie Chung; Jesse Chittams; Danielle Coleman; Karen Glanz
Journal:  J Adv Nurs       Date:  2020-11-29       Impact factor: 3.187

3.  Association between Electronic Cigarette Use and Asthma among High School Students in South Korea.

Authors:  Jun Ho Cho; Samuel Y Paik
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

4.  Real-world Drivers Behind Communication, Medication Adherence, and Shared Decision Making In Minority Adults with Asthma.

Authors:  Allison A Norful; Ani Bilazarian; Annie Chung; Maureen George
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

5.  Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework.

Authors:  Abdullah A Alfaifi; Leanne Lai; Abdullah U Althemery
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.